Phupinder S. Gill
Analyst · BMO Capital Markets
Thank you, John, and thank you, everybody, for joining us this afternoon. I'm going to highlight CME Group's 2012 major efforts, and then share some thoughts about this year. Afterwards, Jamie will review our Q4 financial results. Despite facing a low volatility and difficult environment in 2012, we made significant progress across several key areas as we are embracing the changing regulatory and global landscape. Looking forward to 2013, we remain cautiously optimistic about the trading environment relative to last year. Based on what we have been working on, we feel we are very well positioned to benefit most when we come out of this challenging cycle. We experienced improved activity in December 2012 and January of this year in comparison to what we saw during much of 2012. Average daily volume in December was up 1% year-over-year, with an increase in many asset classes. January average daily volume was 11.4 million, a nice jump from the 10.5 million contracts for daily average during the second half of last year. In addition, open interest is up 13% since the end of the year and is currently above 79 million contracts. Turning to interest rates. The last 2 months were each up versus the prior year. January average daily volume was more than 5.3 million contracts per day, the highest volume levels since June of last year, and up 24% from the 4.3 million average during the second half of last year. The short end of the interest rate curve is still hindered by the 0 interest rate policy, which has negatively impacted Eurodollar activity. On a positive note, our Fed Funds Futures product is currently indicating a rate increase during Q4 of 2014, which has moved up from mid-2015. At the long end of the curve, our treasury products are performing well, with January 2013 average daily volume up 30% versus the same period last year. On February 1, we traded a record number of treasury options approaching 1.2 million contracts, with more than half of that volume on CME Globex. Clearly, market participants are watching economic data very closely with the yield on the 10-year rising above 2% recently. Longer-term catalysts for our interest rate products include the OTC mandate beginning in March, driving more revenue in swap clearing, as well as increased activity in our futures products, the continued resolution of regulatory uncertainty and improved confidence about the economy. In light of these catalysts, we are building our interest rate product suite and our focus remains on driving activity out the curve, examining new interest rate products and building our OTC swap business, which could potentially drive greater use of our core futures and options product. Moving on to OTC. We have seen a ramp-up in activity leading to the CFTC clearing mandate, with Phase 1 step to begin in March. So far, over 60 institutions have cleared trades at CME, comprising a wide array of market participants, including asset managers, hedge funds, insurance companies, GSEs and proprietary trading firms. Since the launch, we have cleared $1.6 trillion, and open interest is above $850 billion. 2013 is off to a good start, with many new customers on-boarding and clearing their first trades and many existing customers increasing their activity. January 2013 average daily notional was over $12 billion, and this compares to $6 billion in the fourth quarter and $4 billion in the third quarter of last year. We also added 8 additional clearing members in 2012, bringing our total to 23. Overall, there are 3 ways for us to help customers navigate the regulatory changes: cleared swaps; existing rate futures contracts; and the new innovative products that we are currently developing and have developed. And we're executing on all these fronts. We now clear the 7 major interest rate swap currencies that account for 95% of the market, 51 CDS indices and the 12 most active emerging markets' NDS. In addition, we received regulatory approval to implement portfolio margining for all market participants. Initial results are promising as these participants have seen significant risk offsets that account for margin savings of over $1 billion. Looking forward, we expect to grow the list of cleared OTC products, as well as launch interest rate swap clearing out of our European clearing house in Q1, well ahead of the mandate there. We also had a successful deliverable swap futures product launch in December with very strong buy and sell side support. There is significant interest in this innovative product and it's off to a great start with approximately 65,000 contracts traded to date, representing $6.5 billion in notional value, and the current open interest lies above 12,000 contracts, which represents about $1.1 billion in notional value. Although we have had nice volume following the launch, many potential clients are focused on the first roll in March and the upcoming clearing mandates in March and June, which will focus more attention on the benefits of this product compared to the alternatives. In addition, we received CFTC approval for our swaps. They are a repository for credit default swaps, interest rate swaps, commodities and FX asset classes. Our SDR will offer customers the ability to optimize their existing connections to CME Clearing for automated SDR reporting, which will facilitate straight-through processing, providing further value to our clients. We are excited about this as a natural extension of the clearing and processing services we offer to both sell and buy side clients, providing a compliant, efficient and low cost way for market participants to access an SDR. Turning to FX. January 2013 average daily volume was up 21% versus the prior year. We are seeing particular strength in the yen and British pound contracts, up 160% and 41%, respectively. FX options continue to be particularly strong, with quarter 4 ADV up 17% versus the prior year and up 56% in January compared to last year. We also hit multiple open interest records for the Japanese yen last week. In terms of open interest, we experienced record levels of FX open interest ending 2012, up 15% compared to the end of 2011. In addition, FX products hit a new all-time high of large open interest holders in December of 890, which is up from 860 in September, indicating that more customers are holding increasing amounts of FX risk at CME Group. Average daily volume in our FX business in December 2012 surpassed the volumes of all the OTC FX platforms for the second time in 6 months. This speaks to both success in building and diversifying our participant base, as well as the FX markets, increasing adoption of exchange-traded and cleared products in the form of CME FX futures and options. We also continue to see improvements and new opportunities within our energy complex. On January 11, the Seaway pipeline increased capacity to 400,000 barrels per day from 150,000 barrels per day, and we saw a tightening of the WTI-Brent spread and look forward to further tightening in the future as more WTI reaches market. In addition, since the 11th, we have seen more volume traded in CME's WTI futures than our competitors' Brent contract. Looking forward, the significant increases projected in U.S. production could lead to more hedging based on TI and lower imports, which are typically linked to Brent. We believe there will be 3 global crude benchmarks going forward: our WTI, Brent, and the DME Oman contracts. We intend to be successful in all 3. Although it is still early in development, we have recently hit record volume levels in our Brent and DME contracts, and open interest in Brent continues to grow. Also, DME Oman is going to be included in a new U.S.-based commodities fund, the United States Asian Commodities Basket Fund, which will give investors exposure to Asia's rapidly growing demand for raw materials. This inclusion recognizes the critical benchmarking role DME is playing in the expansion of the East of Suez markets, providing transparent price discovery and reflecting the economics of the Asian region like no other crude oil futures contract. We are making a very concerted effort to meet the hedging needs of our global client base and expand our market share in 2013 and beyond. Shifting to our globalization efforts. We accomplished a lot in 2012 and look to build on that momentum this year. In 2012, we continued to ramp up our sales and marketing efforts on a global basis, and we have launched a number of regionally specific products, including Black Sea Wheat and Chinese steel rebar swap futures, which are directed towards meeting unique risk management needs in particular geographies. We also continued to expand our global footprint and applied to the Financial Services Authority, or FSA, to register a London-based derivative exchange, CME Europe, which we anticipate launching in mid-2013. In addition, during 2012, we strengthened our international partnerships, including implementing our cross-listing and cross-licensing arrangement with BM&FBOVESPA and increasing our stake in the Dubai Mercantile Exchange to help build the new benchmark for crude oil in the East of Suez that I referenced a short while ago. Lastly, we advanced our efforts in India and China, including helping to facilitate operational readiness of several Chinese FCMs to trade our products and recently launching Indian rupee futures. In addition to our globalization efforts, we continue to enhance and further diversify our core. We completed the acquisition of the Kansas City Board of Trade, and our integration is progressing well since closing the transaction at the end of November. The hard red winter wheat ADV was up 25% in December versus a year ago and the implied inter-exchange wheat futures spread become available on CME Globex on December 10. Our customers will realize further efficiencies as we complete the largest 2 milestones of the integration in the coming year. In mid-April, we will consolidate clearing services under CME Clearing, and we plan to transition all floor trading to Chicago beginning on July 1, subject to the review of the CFTC. Additionally, in 2012, we launched the next generation of CME Globex, reducing order entry and market data latency variability, along with increasing capacity and cost efficiency. We also launched CME Direct technology for online trading at both exchange-traded and the OTC markets. In addition, we closed our joint venture with McGraw-Hill, securing the long-term exclusive license on S&P futures and OTC swaps. And finally, we launched our co-location business to create a valuable new revenue stream and had a successful first year. In summary, we remain extremely focused on future opportunities while investing in the right places and maintaining financial discipline to reward our shareholders. We have a lot to be proud of as a company but a lot of important work still needs to be done. 2013 is going to be a busy year for us, given all that we have planned as we position the firm for future growth. We have prepared for what lies ahead of us, and we look forward to continuing to build upon our world-class businesses. Now I will turn the call over to Jamie to discuss the financials.